A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

Clinical trial NCT03560882 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03560882
Sponsor: Joaquina Baranda
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Disease Solid Tumor Acute Myeloid Leukemia Myelodysplastic Syndromes Cancer Relapsed Hematologic Malignancy

Start date: 2018-07-19
Primary completion: 2022-10-14
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.